|
| Takeda confirms delay in diabetes drug approval |
29 Jun 09, 12:02 |
|
| Japanese drugmaker Takeda Pharmaceutical Co. confirmed Monday that the U.S. Food and Drug Administration will not approve its type 2 diabetes drug candidate alogliptin without more study on its cardiovascular effects. |
| more |
|
